Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors
Chikungunya virus (CHIKV) infection is one of the major public health concerns, leading thousands of cases every year in rural as well as urban regions of several countries worldwide, few to mention are India, Philippines, Indonesia, and also in American countries. The structural and non-structural...
Main Authors: | Prateek Kumar, Deepak Kumar, Rajanish Giri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/8/3/128 |
Similar Items
-
Computational approach to study the synthesis of noscapine and potential of stereoisomers against nsP3 protease of CHIKV
by: Prashant Singh, et al.
Published: (2019-12-01) -
In Silico Screening of Inhibitors of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine Protease
by: Xin Hu, et al.
Published: (2023-07-01) -
Computational probing of Nigella sativa bioactive metabolites against chickungunya nsP2 cysteine protease
by: Sushil Kumar, et al.
Published: (2023-05-01) -
The nsp15 Nuclease as a Good Target to Combat SARS-CoV-2: Mechanism of Action and Its Inactivation with FDA-Approved Drugs
by: Margarida Saramago, et al.
Published: (2022-02-01) -
Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2′-<i>o</i>-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs
by: Ibrahim H. Eissa, et al.
Published: (2022-03-01)